Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studiesIsabel Bergeri, Arash Rashidian, Joseph Okeibunor et al.|PLoS Medicine|2022Cited by 298
Access to Essential Medicines in Pakistan: Policy and Health Systems Research ConcernsShehla Zaidi, Arash Rashidian|PLoS ONE|2013Cited by 89
Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022Isabel Bergeri, Mairead Whelan, Lorenzo Subissi et al.|medRxiv|2021Cited by 42
Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical marketHosein Shabaninejad, Hamid Reza Rasekh, Gholamhossein Mehralian et al.|DARU Journal of Pharmaceutical Sciences|2014Cited by 34
Hospitalization and catastrophic medical payment: evidence from hospitals located in Tehran.Hesam Ghiasvand, Arash Rashidian, Hosein Shabaninejad et al.|PubMed|2014Cited by 22